Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
Background Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface ...
Precision BioSciences (NASDAQ:DTIL) stock gains as company reports promising Phase 1 trial results for its Hepatitis B gene ...
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
News Medical on MSN6d
The growing list of human viruses: Are we prepared for the next outbreak?Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
Precision BioSciences (DTIL) announced initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level of the ...
The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...
On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has ...
TAIPEI (Taiwan News) — A study conducted by National Taiwan University Hospital has uncovered a link between hepatitis B, ...
Introduction: Steatotic liver disease (SLD) can worsen the prognosis of other chronic liver diseases, including viral hepatitis. Objectives: To compare SLD and non-SLD patients with chronic hepatitis ...
Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback